{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:49:48Z","timestamp":1790174988345,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Dipeptidyl peptidase 4 (DPP4) is expressed and secreted by adipocytes. DPP4 induces insulin resistance independently of its effect on glucagon-like peptide 1, thus it is conceivable that DPP4 directly contributes to metabolic dysfunction in patients with morbid obesity. The aim of this study was to investigate the impact of weight loss induced by bariatric surgery on DPP4 activity, and whether these changes are associated with improvements in markers of metabolic dysfunction and fatty liver disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and Methods<\/jats:title>\n                <jats:p>We included 68 non-diabetic patients who underwent bariatric surgery. Serum DPP4 activity was measured using a fluorogenic substrate before and after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Results: After a median follow-up period of 12 (IQR 11-17) months, median serum DPP4 activity decreased from 230 (IQR: 194-273) to 193 (164-252) pmol\/min (p=0.012). The decrease in DPP4 activity was significantly correlated with decreases in BMI, improved cholesterol levels, reduced hepatic injury markers as well as improved post-prandial insulin sensitivity. After multivariable adjustment, \u0394DPP4 activity remained significantly associated with \u0394cholesterol (beta=0.341, p=0.025), \u0394LDL cholesterol (beta=0.350, p=0.019), \u0394gamma-glutamyltransferase (beta=0.323, p=0.040) and \u0394Matsuda index (beta=-0.386, p=0.045).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We demonstrated that weight loss induced by bariatric surgery results in decreased circulating DPP4 activity beyond the initial phase of weight loss. The associations between decreased DPP4 activity and improved cholesterol levels as well as hepatic injury markers point towards pleiotropic effects of DPP4 beyond glucose metabolism which warrant further investigation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11695-020-05200-0","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T10:09:11Z","timestamp":1612433351000},"page":"2545-2550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Decrease of dipeptidyl peptidase 4 activity is associated with weight loss after bariatric surgery"],"prefix":"10.1007","volume":"31","author":[{"given":"Carsten T.","family":"Herz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Brix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Ludvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guntram","family":"Schernthaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9587-1727","authenticated-orcid":false,"given":"Gerit-Holger","family":"Schernthaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"issue":"10","key":"5200_CR1","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1172\/JCI129191","volume":"129","author":"L Vishvanath","year":"2019","unstructured":"Vishvanath L, Gupta RK. Contribution of adipogenesis to healthy adipose tissue expansion in obesity. J Clin Invest. 2019 Oct 1;129(10):4022\u201331.","journal-title":"J Clin Invest."},{"issue":"1","key":"5200_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2012","volume":"93","author":"P Trayhurn","year":"2013","unstructured":"Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013 Jan;93(1):1\u201321.","journal-title":"Physiol Rev."},{"issue":"2","key":"5200_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11883-017-0644-3","volume":"19","author":"L Liberale","year":"2017","unstructured":"Liberale L, Bonaventura A, Vecchi\u00e8 A, et al. The Role of Adipocytokines in Coronary Atherosclerosis. Curr Atheroscler Rep. 2017 Feb;19(2):10.","journal-title":"Curr Atheroscler Rep."},{"issue":"5","key":"5200_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12265-019-09879-0","volume":"12","author":"M Satish","year":"2019","unstructured":"Satish M, Saxena SK, Adipokine Dysregulation ADK. Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae? J Cardiovasc Transl Res. 2019 Oct;12(5):415\u201324.","journal-title":"J Cardiovasc Transl Res."},{"issue":"4","key":"5200_CR5","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.dsx.2019.06.005","volume":"13","author":"R Kumari","year":"2019","unstructured":"Kumari R, Kumar S, Kant R. An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome. Diabetes Metab Syndr. 2019 Jul;13(4):2409\u201317.","journal-title":"Diabetes Metab Syndr."},{"issue":"2","key":"5200_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/iub.1709","volume":"70","author":"T Nargis","year":"2018","unstructured":"Nargis T, Chakrabarti P. Significance of circulatory DPP4 activity in metabolic diseases. IUBMB Life. 2018 Feb;70(2):112\u20139.","journal-title":"IUBMB Life."},{"issue":"7","key":"5200_CR7","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2337\/db10-1707","volume":"60","author":"D Lamers","year":"2011","unstructured":"Lamers D, Famulla S, Wronkowitz N, et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011 Jul;60(7):1917\u201325.","journal-title":"Diabetes."},{"issue":"3","key":"5200_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","volume":"214","author":"R Mentlein","year":"1993","unstructured":"Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem. 1993 Jun 15;214(3):829\u201335.","journal-title":"Eur J Biochem."},{"issue":"10","key":"5200_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","volume":"6","author":"C Baumeier","year":"2017","unstructured":"Baumeier C, Schl\u00fcter L, Saussenthaler S, et al. Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease. Mol Metab. 2017 Oct;6(10):1254\u201363.","journal-title":"Mol Metab."},{"issue":"11","key":"5200_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41574-020-0399-8","volume":"16","author":"CF Deacon","year":"2020","unstructured":"Deacon CF. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020 Nov;16(11):642\u201353.","journal-title":"Nat Rev Endocrinol."},{"issue":"12","key":"5200_CR11","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1007\/s11695-019-04199-3","volume":"29","author":"F Madadi","year":"2019","unstructured":"Madadi F, Jawad R, Mousati I, et al. Remission of Type 2 Diabetes and Sleeve Gastrectomy in Morbid Obesity: a Comparative Systematic Review and Meta-analysis. Obes Surg. 2019 Dec;29(12):4066\u201376.","journal-title":"Obes Surg."},{"key":"5200_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijsu.2020.02.035","volume":"76","author":"Y Han","year":"2020","unstructured":"Han Y, Jia Y, Wang H, et al. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies. Int J Surg. 2020 Apr;76:101\u201310.","journal-title":"Int J Surg."},{"key":"5200_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.coph.2015.09.012","volume":"25","author":"NG Docherty","year":"2015","unstructured":"Docherty NG, Le Roux CW. Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy. Curr Opin Pharmacol. 2015 Dec;25:23\u20139.","journal-title":"Curr Opin Pharmacol."},{"issue":"Suppl 1","key":"5200_CR14","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes","year":"2020","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S14\u201331.","journal-title":"Diabetes Care."},{"issue":"7","key":"5200_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412\u20139.","journal-title":"Diabetologia."},{"issue":"9","key":"5200_CR16","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999 Sep;22(9):1462\u201370.","journal-title":"Diabetes Care."},{"issue":"5","key":"5200_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ijo.2017.31","volume":"41","author":"C Merlotti","year":"2017","unstructured":"Merlotti C, Ceriani V, Morabito A, et al. Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis. Int J Obes. 2017 May;41(5):672\u201382.","journal-title":"Int J Obes"},{"issue":"4","key":"5200_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1463-1326.2011.01358.x","volume":"13","author":"ML Alam","year":"2011","unstructured":"Alam ML, Van der Schueren BJ, Ahren B, et al. Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes. Diabetes Obes Metab. 2011 Apr;13(4):378\u201381.","journal-title":"Diabetes Obes Metab."},{"key":"5200_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fendo.2019.00505","volume":"10","author":"J Sarkar","year":"2019","unstructured":"Sarkar J, Nargis T, Tantia O, et al. Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients. Front Endocrinol. 2019 Jul 25;10:505.","journal-title":"Front Endocrinol"},{"issue":"4","key":"5200_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s13679-016-0237-4","volume":"5","author":"MJ M\u00fcller","year":"2016","unstructured":"M\u00fcller MJ, Enderle J, Bosy-Westphal A. Changes in Energy Expenditure with Weight Gain and Weight Loss in Humans. Curr Obes Rep. 2016 Dec;5(4):413\u201323.","journal-title":"Curr Obes Rep."},{"issue":"3","key":"5200_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11695-017-2913-1","volume":"28","author":"P Jirapinyo","year":"2018","unstructured":"Jirapinyo P, Jin DX, Qazi T, et al. Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy. Obes Surg. 2018 Mar;28(3):615\u201326.","journal-title":"Obes Surg."},{"issue":"6","key":"5200_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065696","volume":"8","author":"CF Hansen","year":"2013","unstructured":"Hansen CF, Bueter M, Theis N, et al. Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats. PLoS One. 2013 Jun 11;8(6):e65696.","journal-title":"PLoS One."},{"issue":"3","key":"5200_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s11605-019-04508-2","volume":"24","author":"SM Russel","year":"2020","unstructured":"Russel SM, Valle V, Spagni G, et al. Physiologic Mechanisms of Type II Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysis and Clinical Implications. J Gastrointest Surg. 2020 Mar;24(3):728\u201341.","journal-title":"J Gastrointest Surg."},{"issue":"12","key":"5200_CR24","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.soard.2017.09.516","volume":"13","author":"L Qi","year":"2017","unstructured":"Qi L, Guo Y, Liu C-Q, et al. Effects of bariatric surgery on glycemic and lipid metabolism, surgical complication and quality of life in adolescents with obesity: a systematic review and meta-analysis. Surg Obes Relat Dis. 2017 Dec;13(12):2037\u201355.","journal-title":"Surg Obes Relat Dis."},{"issue":"3","key":"5200_CR25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ijo.2017.232","volume":"42","author":"C Blanchard","year":"2018","unstructured":"Blanchard C, Moreau F, Ayer A, et al. Roux-en-Y gastric bypass reduces plasma cholesterol in diet-induced obese mice by affecting trans-intestinal cholesterol excretion and intestinal cholesterol absorption. Int J Obes. 2018 Mar;42(3):552\u201360.","journal-title":"Int J Obes"},{"issue":"7","key":"5200_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13017","volume":"21","author":"SSY So","year":"2020","unstructured":"So SSY, Yeung CHC, Schooling CM, et al. Targeting bile acid metabolism in obesity reduction: A systematic review and meta-analysis. Obes Rev. 2020 Jul;21(7):e13017.","journal-title":"Obes Rev."},{"issue":"7","key":"5200_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1463-1326.2012.01568.x","volume":"14","author":"F Briand","year":"2012","unstructured":"Briand F, Thieblemont Q, Burcelin R, et al. Sitagliptin promotes macrophage-to-faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP-apoB100 transgenic mice. Diabetes Obes Metab. 2012 Jul;14(7):662\u20135.","journal-title":"Diabetes Obes Metab."},{"issue":"3","key":"5200_CR28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00125-009-1611-5","volume":"53","author":"J Hsieh","year":"2010","unstructured":"Hsieh J, Longuet C, Baker CL, et al. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. Diabetologia. 2010 Mar;53(3):552\u201361.","journal-title":"Diabetologia."},{"issue":"6","key":"5200_CR29","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdi.12860","volume":"9","author":"M Goto","year":"2018","unstructured":"Goto M, Furuta S, Yamashita S, et al. Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport. J Diabetes Investig. 2018 Nov;9(6):1261\u20139.","journal-title":"J Diabetes Investig."},{"issue":"12","key":"5200_CR30","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1517\/14656566.2015.1057120","volume":"16","author":"K Aoki","year":"2015","unstructured":"Aoki K, Ijima T, Kamiyama H, et al. Anagliptin decreases serum lathosterol level in patients with type 2 diabetes: a pilot study. Expert Opin Pharmacother. 2015 Jun 22;16(12):1749\u201354.","journal-title":"Expert Opin Pharmacother."},{"key":"5200_CR31","doi-asserted-by":"crossref","unstructured":"Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J, et al. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. Gastroenterology. 2015 Aug;149(2):379\u201388; quiz e15-6.","DOI":"10.1053\/j.gastro.2015.04.014"},{"issue":"4","key":"5200_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","volume":"7","author":"N Stefan","year":"2019","unstructured":"Stefan N, H\u00e4ring H-U, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences. and treatment strategies. Lancet Diabetes Endocrinol. 2019 Apr;7(4):313\u201324.","journal-title":"and treatment strategies. Lancet Diabetes Endocrinol."},{"issue":"4","key":"5200_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1665-2681(19)31905-2","volume":"6","author":"YH Balaban","year":"2007","unstructured":"Balaban YH, Korkusuz P, Simsek H, et al. Dipeptidyl peptidase IV (DDP IV) in NASH patients. Ann Hepatol. 2007 Oct;6(4):242\u201350.","journal-title":"Ann Hepatol."},{"issue":"3","key":"5200_CR34","first-page":"729","volume":"5","author":"M Miyazaki","year":"2012","unstructured":"Miyazaki M, Kato M, Tanaka K, et al. Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep. 2012 Mar;5(3):729\u201333.","journal-title":"Mol Med Rep."},{"issue":"6","key":"5200_CR35","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/1753-0407.12237","volume":"7","author":"KH Williams","year":"2015","unstructured":"Williams KH, Vieira De Ribeiro AJ, Prakoso E, et al. Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study. J Diabetes. 2015 Nov;7(6):809\u201319.","journal-title":"J Diabetes."},{"key":"5200_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.metabol.2017.04.012","volume":"73","author":"T Zheng","year":"2017","unstructured":"Zheng T, Chen B, Yang L, et al. Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population. Metabolism. 2017 Aug;73:125\u201334.","journal-title":"Metabolism."},{"issue":"4","key":"5200_CR37","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db10-1338","volume":"60","author":"J Shirakawa","year":"2011","unstructured":"Shirakawa J, Fujii H, Ohnuma K, et al. Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice. Diabetes. 2011 Apr;60(4):1246\u201357.","journal-title":"Diabetes."},{"issue":"6","key":"5200_CR38","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2010.09.032","volume":"54","author":"S Ben-Shlomo","year":"2011","unstructured":"Ben-Shlomo S, Zvibel I, Shnell M, et al. Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol. 2011 Jun;54(6):1214\u201323.","journal-title":"J Hepatol."}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-020-05200-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-020-05200-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-020-05200-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T01:19:25Z","timestamp":1620782365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-020-05200-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5200"],"URL":"https:\/\/doi.org\/10.1007\/s11695-020-05200-0","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"31 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated to add the Open Access funding note.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"CTH, JMB, BL, GS, and GHS declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}